Live from the NIH registry
Studies recruiting near Indio right now
Top 25 of 73 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 30 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
Tornier Perform™ Reversed Monopost Study
Non-inflammatory Degenerative Joint Disease, Rhematoid Arthritis
N/A
Observational 150 participants sought
Eisenhower Health — Rancho Mirage, California (10.2 mi)
· Sponsor: Stryker Trauma and Extremities
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Rancho Mirage, California (10.2 mi)
· Sponsor: Medtronic
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Palm Springs, California (19.0 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Phase 3
Interventional 218 participants sought
Samir Macwan, M.D., Inc. — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Novo Nordisk A/S
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: SWOG Cancer Research Network
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Desert Physicians Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Mayo Clinic
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 3
Interventional 40 participants sought
GC2402 Study Site 104 — Rancho Mirage, California (10.2 mi)
· Sponsor: Grifols Therapeutics LLC
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Idiopathic Pulmonary Fibrosis
Phase 3
Interventional 306 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Trevi Therapeutics
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
HALO Diagnostics — Indian Wells, California (6.3 mi)
· Sponsor: Cleerly, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: GT Medical Technologies, Inc.